Data Engine
Anchored in human reality. One of the most comprehensive spatial transcriptomics databases available today — 2,000+ patient samples and 50M+ spatially resolved cells.
Decoding Diseases with Spatial Intelligence
Revolutionizing Drug Discovery with Spatial Omics and AI-Driven Virtual Tissue Pharmacology.
THE TRANSITION
Biology happens in space
Traditional bulk approaches miss the spatial context of disease. Portrai integrates spatial biology with single-cell information to decode the architecture of the Tumor Microenvironment (TME).
- 2,000+
- Patient samples
- 50M+
- Spatially resolved cells
- 7+
- Cancer types covered
THE PORTRAI PLATFORM
One platform, Three engines A self-reinforcing flywheel
Data, prediction, and validation — each engine makes the others sharper. Every new patient sample refines our models. Every validated asset improves future target discovery.
Prediction Engine
In-silico prediction with spatial precision. Microscopic-PK, Microscopic-PD, and Vision-Gene-Language (VGL Suite) decode the tumor microenvironment for target and toxicity assessment.
Validation Engine
Modality-aware validation. Translate AI insights into physical assets — first computationally, then in tissue, then in vivo. ADC- and RPT-ready.
PIPELINE
Transforming insights into medicines
Advancing a robust pipeline of precision oncology assets, deeply de-risked by our spatial intelligence framework.
- 3 pre-clinical assets (POR001 · POR003 · POR006)
- Modality-aware validation across ADCs & RPTs
- Undisclosed targets — data room on request
PROGRAMMODALITYTARGETPROGRESS
- POR001ADCUndisclosedPre-clinical
- POR003ADCUndisclosedIn-vitro
- POR006RPTUndisclosedIn-vivo
LATEST
From the newsroom
The latest press, company news, and media coverage from Portrai.
Media Coverage-
[🎙️On the Record #7] Meet Portrai, a Seoul startup mapping the human body for drug discovery
Media Coverage-
Beyond the Main Stage: A Showcase of the Next Wave of Korean Biotech Innovation at JPM Week 2026
Media Coverage-
Artificial Intelligence in Radiation Protection of Patients: Diagnostic and therapeutic nuclear medicine
Media Coverage-
Portrai, BL Melanis win Amgen–KHIDI Golden Ticket for 2025 biotech innovation
LET'S BUILD WHAT COMES NEXT
Let's build better therapeutics, together
Partner with Portrai on spatial biology–driven drug discovery, biomarker development, or companion diagnostics.